From: Feasibility of biventricular volume and function assessment using first-pass gated 15O-water PET
Male gender | 14 (74%) |
Age (years) | 65 ± 8 [47–75] |
CCS angor class 1 | 13 (68%) |
CCS angor class 2 | 6 (32%) |
Cardiovascular risk factors | |
BMI > 30 kg/m2 | 3 (16%) |
Diabetes mellitus | 5 (26%) |
Hypertension | 11 (58%) |
> 3 cardiovascular risk factors | 5 (26%) |
Medical therapy | |
Antiplatelet | 17 (89%) |
Beta-blocker | 8 (42%) |
ACE inhibitor or AT-II antagonist | 10 (53%) |
Calcium channel blocker | 3 (16%) |
Long acting nitrates | 2 (11%) |